12
Views
0
CrossRef citations to date
0
Altmetric
Research Article

LITERATURE ALERTS

Pages 117-125 | Published online: 29 Sep 2008

References

  • A highly efficient m icroencapsulated food for rearing early larvae of m arine fish. YUFFRA, M., PASCUAL, E., and FERNANDEZDIAZ, C. A quacu/ture, 1999, 177, 249–256.
  • A new method using fluorescent m icrospheres to determine grazing on ciliates by the m ixotrophic dinoflagellate Ceratium furca. SMALLEY, G. W., COATS, D. W., and ADAM, E. J. Aquatic Microbial Ecology, 1999, 17, 167–179.
  • A new sam ple-processing unit for the fluorescent m icrosphere method. RAAB, S., T HEIN, E., HARRIS, A. G., and MESSMER, K. American Journal of Physiology, 1999, 276 (5 Pt 2), H1801–H1806.
  • A new stabilizer used in m icroencapsulation. LU, Z., BEE, J. Z., and WANG, S. G. Journal of Microencapsulation, 1999, 16, 523–529.
  • A novel influenza subunit vaccine com posed of liposom e-encapsulated haem agglutinin/ neuram inidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice. BABAI, I., SAMIRA, S., BARENHOLZ, Y., ZAKAY RONES, Z., and KEDAR, E. Vaccine, 1999, 17 (9-10), 1223–1238.
  • A novel influenza subunit vaccine com posed of liposom e-encapsulated haem agglutinin/ neuram inidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice. BABAI, I., SAMERA, S., BARENHOLZ, Y., ZAKAY R ONES, Z., and KEDAR, E. Vaccine, 1999, 17 (9-10), 1239–1250.
  • A novel strategy affords high-yield coupling of antibody to extrem ities of liposom al surface-grafted PEG chains. MERCADAL, M DOMINGO, J. C., PETRIZ, J., GARCIA, J., and DE M ADARIAGA, M. A. Biochimica et Biophysica Acta, 1999, 1418 (1), 232–238.
  • A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglo-bulin entrapped in multiphase poly(DL-lactide-co-glycolide) m icrospheres. ROJAS, J., PINTO ALPHANDARY, H., LEO, E., PECQUET, S., COUVREUR, P., GULIK, A., and FATTAL, E. Pharmaceutical Research, 1999, 16 (2), 255–260.
  • A preliminary study of m icrocapsule suspension for hem olysis evaluation of artificial organs. MARUYAMA, O., YAMANE, T., TSUNEMOTO, N., NISHIDA, M., Tsurstll, T., and JIKUYA, T. Artificial Organs, 1999, 23 (3), 274–279.
  • ADP-ribosylation factor 1 dependent clathrin-coat assem bly on synthetic liposom es. ZHU, Y., DRAKE, M. T., and KORNFELD, S. Proceedings of the National Academy Of S ciences (US A ), 1999, 96 (9), 5013–5018.
  • Affinity interaction of hydroxypyruv ate reductase from Methylophilus spp. with Cibacron blue F3GA-derived poly(HEMA EGDMA) m icrospheres: partial purification and char-acterization. ARICA, M. Y., HALICIGEL, C., ALAEDDINOCiLU, G., and DENIZLI, A. Process Biochemistry, 1999, 34, 375–381.
  • Agglom eration of polybutadiene latex by highly carboxylated functional m icrospheres. SHIN, W. C., LEE, H. J., PARK, Y. J., and KIM, J. H. Polymer International, 1999, 48, 479-484. Aggregation kinetics and stability of structures formed by magnetic m icrospheres. WEN, W. J., KUN, F., PAL, K. F., ZHENG, D. W., and T U, K. N. Physical Review E, 1999, 59, R4758-R4761. Album in-loaded PLA and PLGA m icrospheres: in vitro evaluation. FILIPOVIC, G. J., CRC, V., and JALSENJAK, I. Bollettino Chimico Farmaceutico, 1999, 138 (1), 14–18.
  • Alginate encapsulated bioadhesive chitosan m icrospheres for intestinal drug delivery. RAMDAS, M., DILEEP, K. J., ANITHA, Y., PAUL, W., and SHARMA, C. P. Journal of Biomaterials Applications, 1999, 13 (4), 290–296.
  • An optically sensitive membrane for pH based on swellable polymer m icrospheres in a hydrogel. ROONEY, M. T. V., and SELIZ, W. R. Analytical Communications, 1999, 36, 267–270.
  • Assessm ent of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured m icrosphere reference technique. KEMP, P. A., GARDINER, S. M., MARCH, J. E., RUBIN, P. C., and BENNETT, T. British Journal of Pharmacology, 1999, 126 (3), 621–626.
  • Bioabsorbable m icrospheres for local drug release in the articulus. RAMESH, D. V., TABATA, Y., and IKADA, Y. Journal of Bioactive and Compatible Polymers, 1999, 14, 137–149.
  • Bioavailability of m icroencapsulated ferrous sulfate in fluid cows milk. Studies in hum an beings. UICICH, R., PIZARRO, F., ALMEIDA, C., DIAZ, M., BOCCE), J., ZUBILLAGA, M., CARMUEGA, E., and O'DONNELL, A. Nutrition Research, 1999, 19, 893–897.
  • Biocom patibility of poly (DL-lactide-co-glycolide) m icrospheres im planted into the brain. EMERICH, D. F., TRACY, M. A., WARD, K. L., FIGUEIREDO, M., IQIAN, R., HENSCHEL, C., and BARTUS, R. T. Cell Transplantation, 1999, 8 (1), 47–58.
  • Biodegradable alginate m icrospheres as a delivery system for naked DNA. AGGARWAL, N., HOGENESCH, H., GUO, P., NORTH, A., SUCKOW, M., and MITTAL, S. K. Canadian Journal of Veterinary Research, 1999, 63 (2), 148–152.
  • Biodegradable microspheres containing influenza A vaccine: immune response in mice. HIL13ERT, A. K., FRITZSCHE, U., and KISSEL, T. Vaccine, 1999, 17 (9-10), 1065–1073.
  • Biodegradable recombinant hum an erythropoietin loaded microspheres prepared from linear and star-branched block copolym ers: Influence of encapsulation technique and polymer corn position on particle characteristics. PISTEL, K. F., BITTNER, B., KOLL, H., WINTER, G., and KISSEL, T. Journal of Controlled Release, 1999, 59, 309–325.
  • Clq binding to liposom es is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the hum an ClqA chain in a sequence independent manner. BRADLEY, A. J., BROOKS, D. E., NORRIS JONES, R., and DEVINE, D. V. Biochimica et Biophysica Acta, 1999, 1418 (1), 19–30.
  • Cellular uptake and delivery monitoring of liposom e/DNA complexes during in vitro transfection of CFTR gene. SERAFINO, A. L., NOVELLI, G., DI S ARIO, S., COLOSIMO, A., AMICUCEI, P., S ANGIUOLO, F., MOSSA, G., and DALLAPICCOLA, B. Biochemistry and Molecular Biology International, 1999, 47 (2), 337–344.
  • Cephradin-plaga microspheres for sustained delivery to cattle. USTARIZ PEYRET, C., COUDANE, J., VERT, M., KALTSATOS, V., and BOISRAME, B. Journal of Microencapsulation, 1999, 16 (2), 181–194.
  • Cerebroside-beta-glucosidase encapsulation in liposom es for Gaucher's disease treatm ent revisited. KORABLYOV, V., ZIMRAN, A., BARENHOLZ, Y. Pharmaceutical Research, 1999, 16 (3), 466–469.
  • Characterization of endotoxin and cationic liposom e interaction. PDXON, S. W., and HUGHES, J. A. Pharmaceutical Development and Technology, 1999, 4 (2), 135–143.
  • Coacervate microspheres as carriers of recom binant adenoviruses. KALYANASUNDARAM, S., FEINSTEIN, S., NICHOLSON, J. P., LEONG, K. W., and GARVER, R. I. Cancer Gene Therapy, 1999, 6, 107–112.
  • Comparison of in vitro activity of liposom al nystatin against Aspergillus species with those of nystatin, am photericin B (AB) deoxycholate, AB colloidal dispersion, liposom al AB, AB lipid complex, and itraconazole. OAKLEY, K. L., MOORE, C. B., and DENNING, D. W. Antimicrobial Agents and Chemotherapy, 1999, 43 (5), 1264–1266.
  • Corn plem ent-m ediated acute effects of liposom e-encapsulated hem oglobin. SZEBENI, J., and ALVING, C. R. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1999, 27 (1), 23–41. 64 Refs.
  • Controlled release of a model protein from enzym atically degrading dextran microspheres. FRANSSEN, O., STENEKES, R. J. H., and HENNINK, W. E. Journal of Controlled Release, 1999, 59, 219–228.
  • Correlation of flow probe determinations of comm on carotid artery blood flow and internal carotid artery blood flow with microsphere determinations of cerebral blood flow in piglets. MEADOW, W., RUDINSKY, B., RAJU, T JOHN, E., FORNELL, L., and S HANKARARAO, R. Pediatric Research, 1999, 45 (3), 324–330.
  • Culture of microencapsulated neonatal porcine islets is associated with an increased proportion of beta cells cellular insulin content and elevated expression of IDX-1. KORBUIT, G. S., RAYAT, G. R., RAE:TETE, R. V., and KIEFFER, T. J. 1999, Si, 48.
  • Detection of sparse botulinum toxin A binding sites using fluorescent latex microspheres. CROSLAND, R. D., and CANZIANI, G. A. Journal of Histotechnology, 1999, 22, 113–115.
  • Determination of the entrapped volume of liposom es: dilution method. KAWAKAMI, K., NISHIHARA, Y., and HIRANO, K. Analytical Biochemistry, 1999, 269 (1), 139–142.
  • Developm ent of novel cationic liposom es for efficient gene transfer into peritoneal dissem i-nated tumor. KIKUCHI, A., AOKI, Y., SUGAYA, S., SERIKAWA, T., T AKAKUWA, K., TANAKA, K., SUZUKI, N., and KIKUCHI, H. Human Gene Therapy, 1999, 10 (6), 947–955.
  • Dextran cross-linked gelatin microspheres as a drug delivery system. CORTESI, R., ESPOSITO, E., OSTI, M ., SQUARZONI, G., M ENEGATTI, E., DAVIS, S S., and N ASTRUZZI, C. European Journal of Pharmaceutics and Biopharmaceutics, 1999, 47 (2), 153–160.
  • Differential transm em brane diffusion of triiodothyronine and thyroxine in liposom es: regulation by lipid composition. CHEITIN, R. N., ISSE, B. G., RINTOUL, M. R., and FARIAS, R. N. Journal of Membrane Biology, 1999, 167 (3), 251–256.
  • Diphtheria and tetanus toroid m icroencapsulation into conventional and end-group alky-late d PLA PLGAs. JOHANSEN, P., T AMBER, H., MERKLE, H. P., and GANDER, B. European Journal of Pharmaceutics and Biopharmaceutics, 1999, 47, 193–201.
  • Dual effect of alkylresorcinols, natural am phiphilic compounds, upon liposom al perm eabil-ity. GUBERNATOR, J., S TASIUK, M., and KOZUBEK, A. Biochimica et Biophysica Acta, 1999, 1418 (2), 253–60.
  • Early detection of liposome brain localization in rat experimental allergic encephalomye-litis. ROUSSEAU, V., DENIZOT, B., LE JEUNE, J. J., and JALLET, P. Experimental Brain Research, 1999, 125 (3), 255–264.
  • Effect of form ulation variables on in vitro drug release and micromeritic properties of modified release ibuprofen microspheres. PERUMAL, D., DANGOR, C. M., ALCOCK, R. S., HURBANS, N., and MOOPANAR, K. R. Journal of Microencapsulation, 1999, 16, 475–487.
  • Effect of liposom es on mineralization in rat osteoblast-enriched cultures. HUANG, J. S., WU, H. F., HONG, J. M., CHANG, F. H., and HONG, K. Kao-Hsiung I Hsueh Ko Hsueh T sa Chih (Kaohsiung Journal of Medical Sciences), 1999, 15 (4), 187–194.
  • Effect of manufacturing conditions on the form ation of double-w ailed polymer micro-spheres. LEACH, K., NOH, K., and MATIHOWITZ, E. Journal of Microencapsulation, 1999, 16 (2), 153–167.
  • Effect of solvent on the characteristics of pentam idine loaded m icrocapsule. MANDAL, T. K. Journal of Biomaterials Science, Polymer Edition, 1999, 10 (1), 1–17.
  • Efficacy of microencapsulated rifam pin in Mycobacterium tuberculosis-infected mice. QUENELLE, D. C., STAAS, J. K., WINCHESTER, G. A., BARROW, E. L., and BARROW, W. W. Antimicrobial Agents and Chemotherapy, 1999, 43 (5), 1144–1151.
  • Electric field-induced transient birefringence and light scattering of synthetic liposom es. ASGHARIAN, N., and SCHELLY, Z. A. Biochimica et Biophysica Acta, 1999, 1418 (2), 295–306.
  • Electron param agnetic resonance studies of membrane fluidity in ozone-treated erythro-cytes and liposom es. WROBEL, A., and GOMULKLEWICZ, J. Biochemistry and Molecular Biology International, 1999, 47 (1), 99–105.
  • Electrorheological fluids of coated m icrospheres. YU, K. W., WAN, J. T. K., LAW, M. F., and LEUNG, K. K. International Journal of Modern Physics C, 1998, 9, 1447–1457.
  • Encapsulation and release of rhodium (II) citrate and its association complex with hydro-xypropyl-beta-cyclodextrin from biodegradable polym er microspheres. SINISTERRA, R. D., SHASTRI, V. P., NAJJAR, R., and LANGER, R. Journal of Pharmaceutical Sciences, 1999, 88 (5), 574–576.
  • Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres. STURESSON, C., A RTURSSON, P., GHADERI, R., JOHANSEN, K., M IRAZIMI, A., U HNOO, I S VENSSON, L., A LBERTSSON, A. C., and CARLFORS, J. Journal of Controlled Release, 1999, 59, 377–389.
  • Enhancem ent of antitumor activity of polyethylene glycol-coated liposom al doxorubicin with soluble and liposom al interleukin 2. CABANES, A., EVEN CHEN, S., ZIMBEROFF, J., BARE'NHOLZ, Y., KEDAR, E., and GARIZON, A. Clinical Cancer Research, 1999, 5 (3), 687–693.
  • Enzym atic degradation of epichlorohydrin crosslinked starch microspheres by alpha-amy-lase. HAMDI, G., and PONCHEL, G. Pharmaceutical Research, 1999, 16, 867–875.
  • Evaluation of cationic liposome suitable for gene transfer into pregnant anim als. OCHIYA, T., T AKAHAMA, Y., BABA T ORIYAMA, H., T SUKAMOTO, M., YASUDA, Y., KIKUCHI, H., and T FRADA, M. Biochemical and Biophysical Research Communications, 1999, 258 (2), 358–365.
  • Evaluation of microspheres containing cytokine neutralizing antibodies in endotoxem ia. DSOULA, M. J., ()HUNGER, C. W., and MILTON, G. V. Drug Development and Industrial Pharmacy, 1999, 25, 727–734.
  • Fabrication, characterization and evaluation of bioceramic hollow microspheres used as microcarriers for 3-D bone tissue form ation in rotating bioreactors. QIU, Q. Q., DUCHEYNE, P., and AYYAswAmY, P. S. Biomaterials, 1999, 20, 989–1001.
  • Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. TRACY, M. A., WARD, K. L., FIROUZABADIAN, L., WANG, Y., DONG, N., QIAN, R., and ZHANG, Y. Biomaterials, 1999, 20, 1057–1062.
  • Features of transfection and expression of cDNA for the hum an dystrophin gene, delivered into muscles of mdx mice using MF-2 synthetic m icrospheres. BARANOV, A. N., KISELEV, A. V., IVASHCHENKO, T. E., KASHCI1EEVA, T. K., and BARANOV, V. S. Genetika, 1999, 35 (1), 22–27.
  • Fiber-optic add-drop device based on a silica microsphere-whispering gallery mode system. CAI, M., HUNZIKER, G., and VAHALA, K. IEEE Photonics Technology Letters, 1999, 11, 686–687.
  • Flow cytom etric and optical microscopic evaluation of poly(), L-lactide-co-glycolide) micro-spheres phagocytosis by pig alveolar m acrophages. T ORCHE, A. M., ALBINA, E., LE CORRE, P., JESTIN, A., and LE VERGE, R. Journal of Controlled Release, 1999, 58 (3), 289–301.
  • Fluorescence imaging of single m olecules in polym er m icrospheres. BARNES, M. D., NG, K. C., MCNAMARA, K. P., KUNG, C. Y., RAMSEY, J. M., and HILL, S. C. Cytometry, 1999, 36, 169–175.
  • Form ulation of controlled release microspheres containing nicardipine: the role of pharm a-cokin etic modeling and computer sim ulation. MAHAR, A., BOGATAJ, M., GRABNAR, I., and KAABA, R. European Journal of Drug Metabolism and Pharmacokinetics, 1999, 24, 55–61.
  • Freeze-thaw immobilization of liposom es in chrom atographic gel beads: evaluation by con focal microscopy and effects of freezing rate. L UNDQVIST, A., OCKLIND, G., H ANESKOG, L., and L UNDAHL, P. Journal of Molecular Recognition, 1998, 11 (1-6), 52–57.
  • FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. Fu, K., GRIEBENOW, K., H SIEH, L., K LIBANOV, A. M., and L ANGER, R. Journal of Controlled Release, 1999, 58 (3), 357–366.
  • Gene expression and antitumor effects following direct interferon (IFN)-gamm a gene transfer with naked plasm id DNA and DC-chol liposome complexes in m ice. N OMURA, T., Y ASUDA, K., Y AMADA, T., OKAMOTO, S., M AHATO, R. I., WATANABE, Y., TAKAKURA, Y., and H ASHIDA, M. Gene Therapy, 1999, 6 (1), 121–129.
  • Glucose metabolism in vitro of cultured and transplanted mouse pancreatic islets micro-encapsulated by means of a high-voltage electrostatic field. KING, A., S ANDLER, S., ANDERSSON, A., HELLERSTROM, C., K ULSFNG, B., and S KJAK- BRAEK, G. Diabetes Care, 1999, 22 (Suppl 2), B121–B126.
  • Growth kinetics of genetically engineered E. coli DH 5 cells in artificial cell APA membrane microcapsules: preliminary report. PRAKASH, S., and CHANG, T. M. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1999, 27 (3), 291–301.
  • Hepatic radioem bolization with Yttrium-90 glass microspheres for treatm ent of prim ary liver cancer. C AO, X. C., HE, N. S., SUN, J. Z., TAN, J., Z HANG, C. L., YANG, J. G., LU, T. W., and LI, J. H. Chinese Medical Journal, 1999, 112, 430–432.
  • Hepatic uptake of polystyrene m icrospheres in rats: effect of particle size on intrahepatic distribution. OGAWARA, K., YOSHIDA, M HIGAKE, K., KIMURA, T SHIRAISHI, K., NISHIKAWA, M., T AKAKURA, Y., and H ASHIDA, M. Journal of Controlled Release, 1999, 59 (1), 15–22.
  • Heterodim er-loaded erythrocytes as bioreactors for slow delivery of the antiviral drug azidothymidine and the antimycobacterial drug ethambutol. ROSSI, L., BRANDI, G., SCHIAVANO, G. F., SCARFI, S., Min°, E., D AMONTE, G., BENATTE U., D E FLORA, A., and M AGNANI, M. Aids Research and Human Retroviruses, 1999, 15 (4), 345–353.
  • Im m unoadjuvant action of plasm id DNA in liposom es. GURSEL, M T UNCA, S., OZKAN, M ., OzcENGtz, G., and A LAEDDINOGLU, G. Vaccine, 1999, 17 (11-12), 1376–1383.
  • Im m unogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposom es. CHANG, J. S., CHOI, M. J., KIM, T. Y., CHO, S. Y., and CHEONG, H. S. Vaccine, 1999, 17 (11-12), 1540–1548.
  • Im proved efficacy of a microencapsulated m acrophage colony stimulating factor and m ethotrexate in m elanom a. DSOUZA, M. J., and POURFARZIB, R. Drug Development and Industrial Pharmacy, 1999, 25 (5), 583–590.
  • Im proved protocol for a microsphere-adhesion assay on living tissue slices. F ORSTER, E., and KAurscHmIDT, C. Biotechniques, 1999, 26 (3), 466–468. 470, 472.
  • Im provem ent of tem perature-sensitivity of poly(N-isopropylacrylam ide)-m odified lipo-som es. K ONO, K., H ENMI, A., Y AMASHITA, H., H AYASHI, H., and T AKAGISHI, T. Journal of Controlled Release, 1999, 59 (1), 63–75.
  • In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems. CHARY, R. B., V ANT, G., and R AO, Y. M. Drug Development and Industrial Pharmacy, 1999, 25 (5), 685–690.
  • In vitro oligom erization of a mem brane protein coin plex. liposome-based reconstitution of trim eric photosystem I from isolated monomers. K RUIP, J., K ARAPETYAN, N. V., TEREKHOVA, I. V., and ROGNER, M. Journal of Biological Chemistry, 1999, 274 (26), 18181–18188.
  • In vivo fate and immune pulm onary response after nasal administration of microspheres loaded with ph osph orylcholine-th yroglobulin. T ROLLE, S., CAUDRON, E., LEO, E., COUVREUR, P., A NDREMONT, A., and F ATTAL, E. International Journal of Pharmaceutics, 1999, 183, 73–79.
  • Interaction between anionic molecule and colored copolypeptide microspheres. NAKANISHI, E., SUGIMOTO, H., KAMIYA, M., and HIBI, S. Polymer Bulletin, 1999, 42, 395–401.
  • Interaction of cationic liposom es and their DNA complexes with monocytic leukemia cells. PIERS, P., S IMOFS, S NIA, S G ASPAR, R., D UZGUNES, N., and PEDROSO DE LIMA, M. C. Biochimica et Biophysica Acta, 1999, 1418 (1), 71–84.
  • Interaction of liposom es coin posed of phospholipids, GM1 ganglioside and cholesterol with hum an keratinocytes in culture. PITTO, M PALESTINE P., F ERRARETTO, A., M ARAZZI, M ., D ONATI, V., F ALCONE, L., and M ASSERINI, M. Archives of Dermatological Research, 1999, 291 (4), 232–237.
  • Interactions of an antim icrobial peptide, m againin 2, with lipopolysaccharide-containing liposom es as a model for outer membranes of gram-negative bacteria. M AT SUZAKI, K., SUGISHITA, K., and M IYAJIMA, K. Febs Letters, 1999, 449 (2-3), 221–224.
  • Interferon incorporated into liposom es. A method for the design of homologous and hetero-logous liposom es and the control of their in-vivo permeability. KALENIK, T. K., M OTAVKINA, N. S., and V OROB- EV, A. A. Zhurna/ Mikrobio/ogii, Epidemio/ogii I Immunobiologii, 1999, Mar-Apr (2), 15–19.
  • Intestinal ischem ia reperfusion (I/R) injury results in the transference of m icrospheres through the m esenteric lymphatics into the intestinal m uscularis via extravasating m onocytes. BOLEA, C., SCHWARZ, N. T., AUDOLFSSON, G., and BAUER, A. J. Gastroenterology, 1999, 116, G4181.
  • Investigation of lipid peroxidation in liposom es induced by heavy ion irradiation. ZIEGLER, C., and WESSELS, J. M. Radiation and Environmental Biophysics, 1998, 37 (2), 95–100.
  • Investigations into the structure and corn position of beta-cyclodextrin/poly(acrylic acid) microspheres. BIBBY, D. C., DAVIES, N. M., and TUCKER, I. G. International Journal of Pharmaceutics, 1999, 180 (2), 161–168.
  • Key param eters for m onodispersed polymer microspheres with spinning disk atom ization. SENUMA, Y., and HLLBORN, J. G. Materials Research Innovations, 1999, 3, 42–49.
  • Lasing threshold for w hispering-gallery-m ode microsphere lasers. WU, Y., and LEUNG, P. T. Physical Review A, 1999, 60, 630–633.
  • Liposom al am photericin (Am Bisom e) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. KELSEY, S. M., GOLDMAN, J. M., MCCANN, S., NEWLAND, A. C., SCAREEE, J. H., OPPENHEM, B. A., and MUFTI, G. J. Bone Marrow Transplantation, 1999, 23 (2), 163–168.
  • Liposom al daunorubicin (DaunoXome) in children with recurrent or progressive brain tum ors. LIPPENS, R. J. Pediatric Hematology and Oncology, 1999, 16 (2), 131–139.
  • Liposom e gene delivery system. LANGNER, M. Postepy Biochemii, 1998, 44 (4), 299-305. 88 Refs. Liposom e microencapsulations without using any organic solvent. ZHENG, S., ALKANONYUKSEL, H., BENSINGER, R. L., and WASAN, D. T. Journal of Dispersion Science and Technology, 1999, 20, 1189–1203.
  • Liposom e-induced release of cell m ern brane proteins from intact tissue epithelium . NAKAMURA, M., T SUFI, K., and SUNAMOTO, J. Medical and Biological Engineering and Computing, 1998, 36 (5), 645–653.
  • Liposom e-m ediated im munotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC. WONG, J. P., YANG, H., NAGATA, L., KENDE, M., LEVY, H., SCHNELL, G., and BLASETTI, K. Vaccine, 1999, 17 (13-14), 1788–1795.
  • Liposom es and other nanoparticles as drug delivery systems. KAPLUN, A. P., SON, L. B., KRASNOPOLSKII, IUM., and SHVETS, V. I. V oprosy Meditsinskoi Khimii, 1999, 45 (1), 3–12. 50 Refs.
  • Liposom es as a topical delivery system: the role of size on transport studied by the EPR imaging method. SENTJURC, M., VRHOVNIK, K., and KRISTL, J. Journal of Controlled Release, 1999, 59 (1), 87–97.
  • Liposom es as carriers of the an tiretroviral agent dideoxycytidine-5"-triphosphate. OUSSOREN, C., MAGNANI, M., FRATERNALE, A., CASABIANCA, A., CHIARANTINI, L., INGFBRIGSTEN, R., UNDERBERG, W. J., and STORM G. International Journal of Pharmaceutics, 1999, 180 (2), 261–270.
  • Liposom es with incorporated MHC class II/peptide coin plexes as antigen presenting vesicles for specific T cell activation. VAN RENSEN, A. J., WAUBEN, M. H., GROSFELD STULEMEYER, M. C., VAN EDEN, W., and CROMMELIN, D. J. Pharmaceutical Research, 1999, 16 (2), 198–204.
  • Master-equation model of a single-quantum -dot m icrosphere laser. BENSON, O., and YAMAMOTO, Y. Physical Review A, 1999, 59, 4756–4763.
  • Metal ion imprinted m icrosphere prepared by surface molecular imprinting technique using w ater-in-oil-in-w ater emulsions. YOSHIDA, M., UEZU, K., GOTO, M., and FURUSAKI, S. Journal of Applied Polymer Science, 1999, 73, 1223–1230.
  • Metal-im printed m icrosphere prepared by surface tern plate polymerization with W/O/W em ulsions. UEZU, K., NAKAIVIURA, H., Goro, M., NAKASHIO, F., and FURUSAKL S. Journal of Chemical Engineering of Japan, 1999, 32, 262–267.
  • Meth oxybutropate m icroencapsulation by gelatin-acacia corn pie x coacervation. PALMIERI, G. F., LAURI, D., MARTELLI, S., and WEHRLE, P. Drug Development and Industrial Pharmacy, 1999, 25 (4), 399–407.
  • MHC class I- and class II-restricted processing and presentation of m ic roenc apsu late d antigens. MEN, Y., A UDRAN, R., T HOMASIN, C., EBERL, G., DEMCT2, S., MERKLE, H. P., GANDER, B., and CORRADIN, G. Vaccine, 1999, 17 (9-10), 1047–1056.
  • Microagglom eration of pulverized pharm aceutical pow ders using the Wurster process I. Preparation of highly drug-incorporated, subsieve-sized core particles for subsequent m icroen capsulation by film-coating. ICHIKAWA, H., and FUKUMORI, Y. International Journal of Pharmaceutics, 1999, 180, 195–210.
  • Microcavities combining a semiconductor with a fused-silica microsphere. FAN, X. D., LACEY, S., and WANG, H. L. Optics Letters, 1999, 24, 771–773.
  • Microencapsulation and testing of the agricultural animal repellent, Daphne. BOB; B., KCSIR, I., KNEZ, E., KUKOWC, M., SKERLAvm, V., and SKvARc, A. Journal of Microencapsulation, 1999, 16 (2), 169–180.
  • Microencapsulation inhibits protease release from pancreatic supplements in-vivo. DEUTSCH, J. C., CZOPEK, M., R ODMAN, D., and KOLHOUSE, J. F. Gastroenterology, 1999, 116, G4848.
  • Microencapsulation of single rat pancreatic islets with preserved secretory potential. OLIVARES, E., NILSSON, K., and M ALAISSE, W. J. Medical Science Research, 1999, 27, 411–413.
  • Microencapsulation of the water-soluble pesticide Monocrotophos by an oil in oil interfacial polyaddition method. S HUKLA, P. G., and S IVARAM, S Journa of Microencapsuiation, 1999, 16, 517–521.
  • Microencapsulation: Offering solutions for the food industry. BRAZEL, C. S. Cereal Foods World, 1999, 44, 388 (5 pages).
  • Microsphere embolism -induced elevation of nerve growth factor level and appearance of nerve growth factor immunoreactivity in activated T-lymphocytes in the rat brain. MizumA, H., T AKAGI, K., M IYAKE, K., T AKAGI, N., ISHIDA, K., T AxEo, S., NITTA, A., Nomaro, H., FURUKAWA, Y., and FURUKAWA, S. Journal of Neuroscience Research, 1999, 55 (6), 749–761.
  • Microspheres of chitosan/poly(vinylalcohol) incorporating tetrasulphonated copper (II) phthalocyanine: preparation and characterization. S TOLBFRG, J., L ARANJEERA, M. C. M., S ANCHEZ, M. N. M., KLUG, M., and FAVERE, V. T. Journal of Microencapsulation, 1999, 16, 431–438.
  • Mitosis enhances transgene expression of plasm id delivered by cationic liposom es. TSENG, W. C., HASELTON, F. R., and GIORGtO, T. D. Biochimica et Biophysica Acta, 1999, 1445 (1), 53–64.
  • Modulated release of IdUrd from poly (0,1,-lactide-co-glycolide)m icrospheres by addition of poly (D, L-lactide) oligomers. GEZE, A., VENTER, J. M. C., S AULNIER, P., VARLET, P., D AUMAS, D. C., DEVAUCHELLE, P., and BENOIT, J. P. Journal of Controlled Release, 1999, 58 (3), 311–322.
  • Monodisperse poly(chloromethylstyrene-co-divinylbenzene) microspheres by precipitation polym erization. LI, W. H., LI, K., and STOVER, H. D. H. Journal of Polymer Science, Part A-Polymer Chemistry, 1999, 37, 2295–2303.
  • Motility of ActA protein-coated m icrospheres driven by actin polymerization. CAMERON, L. A., FOOTER, M. J., VAN OuDENAARDEN, A., and TB:mar, J. A. Proceedings of the National Academy Of Sciences (USA), 1999, 96 (9), 4908–4913.
  • Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibro-blast growth factor. T ABATA, Y., HIJIKATA, S M UNIRUZZAMAN, M., and TRAM, Y. Journal of Biomaterials Science, Polymer Edition, 1999, 10 (1), 79–94.
  • NF-kappa B, liposom es and pathogenesis of hepatic injury and fibrosis. Wu, J., and ZERN, M. A. Frontiers in Bioscience, 1999, 4, D520-D527, 67 Refs.
  • Non-contact percolation and conductivity in microsphere composites. OLIVER°, D. A., and RADFORD, D. W. Journal of Advanced Materials, 1999, 31, 42–50.
  • Novel drug delivery microspheres from poly(1,5-dioxepan-2-one-co-L-lactide). EDLUND, U., and A LBERTSSON, A. C. Journal of Polymer Science, Part A-Polymer Chemistry, 1999, 37, 1877–1884.
  • O/W lipid em ulsions for parenteral drug delivery. III. Lipophilicity necessary for incorpora-tion in oil particles even after intravenous injection. S AKARDA, T., and HIRANO, K. Journal of Drug Targeting, 1998, 6 (2), 119–127.
  • O/W lipid em ulsions for parenteral drug delivery. IV. Changes in the ph arm acokinetics and pharm acodynamics of a highly lipophilic drug, menatetrenone. S AKAEDA, T., KAKUSHI, H., S HIKE, T., T AKANO, K., HARAUCIR, T., HIRATA, M., and HIRANO, K. Journal of Drug Targeting, 1998, 6 (3), 183–189.
  • Observation of a modulation effect caused by a microsphere resonator strongly coupled to a dielectric substrate. ISHIRAWA, H., TAMARU, H., and MIYANo, K. Optics L etters, 1999, 24, 643–645.
  • Ocular drug targeting by liposom es and their corneal interactions. VELPANDIAN, T., GUPTA, S. K., GUPTA, Y. K., BISWAS, N. R., and A GARWAL, H. C. Journal of Microencapsulation, 1999, 16 (2), 243–250.
  • Oligonucleotide uptake in cultured keratinocytes: influence of confluence, cationic lipo-som es, and keratin ocyte cell type. WHITE, P. J., FOGARTY, R. D., MCKEAN, S C., V ENABLES, D. J., W ERTHER, G. A., and WRAIGHT, C. J. Journal of Investigative Dermatology, 1999, 112 (5), 699–705.
  • On the mechanism of hepatic transendothelial passage of large liposom es. R OMERO, E. L., M ORILLA, M. J., REGTS, J., KONING, G. A., and S CHERPHOF, G. L. Febs Letters, 1999, 448 (1), 193–196.
  • One-m onth sustained release microspheres of 125I-bovine calcitonin. In vitro-in vivo studies. DIAZ, R. V., LLABRES, M., and EVORA, C. Journal of Controlled Release, 1999, 59 (1), 55–62.
  • Optim ization of cationic liposom e-mediated gene transfer to hum an bronchial epithelial cells expressing wild-type or abnormal cystic fibrosis transm em brane conductance regulator (CFTR). PETERS, M. T., BRIGHAM, K. L., KING, G. A., MEYRICK, B. O., GAO, X., and STECENKO, A. A. Experimental Lung Research, 1999, 25 (3), 183–197.
  • Optim ization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) m icrospheres. ROJAS, J., PINToALRHANDARy, H., LED, E., PECQUET, S., COUVREUR, P., and FATTAL, E. International Journal of Pharmaceutics, 1999, 183, 67–71.
  • Oral vaccination of an im als with antigens encapsulated in alginate m icrospheres. BOWERSOCK, T. L., HooENEscH, H., SUCKOW, M., GulmoNo, P., MARTIN, S., BORE, D., T CRRECROSA, S., PARK, H., and PARK, K. Vaccine, 1999, 17 (13-14), 1804–1811.
  • pH and osm otic pressure inside biodegradable m icrospheres during erosion. BRUNNER, A., M ADER, K., and G OPEERICH, A. Pharmaceutical Research, 1999, 16, 847–853.
  • Pharm acokinetics and urinary excretion of am ikacin in low -clearance unilam ellar lipo-som es after a single or repeated intravenous adm inistration in the rhesus monkey. FIELDING, R. M., M CON M CD ERMOTT,.L, LEWIS, R. O., and HORNER, M. J. Antimicrobial Agents and Chemotherapy, 1999, 43 (3), 503–509.
  • Phase II trial of high-dose liposom e-encapsulated doxorubicin with granulocyte colony-stim ulating factor in m etastatic breast cancer. TLC D-99 Study Group. SHAPIRO, C. L., ERVIN, T., WELLES, L., AZARNIA, N., KEATING, J., and HAYES, D. F. Journal of Clinical Oncology, 1999, 17 (5), 1435–1441.
  • Phase II trial of liposom e-encapsulated doxorubicin, cyclophospham ide, and fluorouracil as first-line therapy in patients with m etastatic breast cancer. VALERO, V., BUZDAR, A. U., THERIAULT, R. L., AZARNIA, N., FONSECA, G. A., WILLEY, J., EWER, M., WALTERS, R. S., MACKAY, B., PODOLOFF, D., BOXER, D., LEE, L. W., and HORTOBAGYI, G. N. Journal of Clinical Oncology, 1999, 17 (5), 1425–1434.
  • Phase behavior of fluorocarbon and hydrocarbon double-chain hydroxylated and galactosy-lated am phiphiles and bolaam phiphiles. Long-term shelf-stability of their liposom es. CLARY, L., GADRAS, C., GREINER, J., ROLLAND, J. P., SANTAELLA, C., VIERLING, P., and GUL1K, A. Chemistry and Physics of Lipids, 1999, 99 (2), 125–137.
  • Phase inversion dynamics of PLGA solutions related to drug delivery. GRAHAM, P. D., BRODBECK, K. J., and MCHUGH, A. J. Journal of Controlled Release, 1999, 58 (2), 233–245.
  • Pigtailing the high-Q m icrosphere cavity: a sim ple fiber coupler for optical whispering-gallery m odes. ILCHENKO, V. S., YAO, X. S., and MALEIU, L. Optics L etters, 1999, 24, 723–725.
  • Polym ers for sustained release form ulations of dipyridam ole-alginate m icrospheres and tabletted m icrospheres. GURSOY, A., KARAKUS, D., and OKAR, I. Journal of Microencapsula-tion, 1999, 16, 439–452.
  • Positively and negatively charged subm icron em ulsions for enhanced topical delivery of antifungal drugs. PIEIvII, M. P., KORNER, D., BENITA, S., and MARTY, J. P. Journal of Controlled Release, 1999, 58 (2), 177–187.
  • Potential applications for gelatin isolated from chromium -containing solid tannery waste: Microencapsulation. CABEZA, L. F., TAYLOR, M. M., BROWN, E. M., and MARMER, W. N. Journal of the American Leather Chemists Association, 1999, 94, 182–189.
  • Potential for improved therapeutic index of FK506 in liposom al form ulation dem onstrated in a mouse cardiac allograft model. MOFFATT, S. D., MCALISTER, V., CALNE, R. Y., and METCALFE, S. M. Transplantation, 1999, 67 (9), 1205–1208.
  • Preparation and characterization of poly (D, L-lactide-co-glycolide) m icrospheres for con-trolled release of poly(L-lysine) com plexed plasm id DNA. CAPAN, Y., Woo, B. H., GEBREKIDAN, S., AHMED, S., and DELUCA, P. P. Pharmaceutical Research, 1999, 16 (4), 509–513.
  • Preparation and morphology studies of core-shell type w aterborne polyacrylate-polyur-ethane m icrospheres. DONG, A. J., AN, Y. L., FENG, S. Y., and SUN, D. X. Journal of Colloid and Interface Science, 1999, 214, 118–122.
  • Preparation of album in m icrospheres by an improved process. KATTI, D., and KRISHNAMURTI, N. Journal of Microencapsulation, 1999, 16(2), 231–242.
  • Preparation of liposom es by reverse-phase evaporation using alternative organic solvents. CORTESI, R., ESPOSITO, E., GAMBARIN S., T ELLOLI, P., MENEGATTI, E., and NASTRUZZI, C. Journal of Microencapsulation, 1999, 16 (2), 251–256.
  • Preparation of poly-DL-lactide-b-polyethylene glycol m icrospheres encapsulating hum an serum album inLA-Chinese. LI, X. H., YUAN, M. L., XIONG, C. D., DENG, X. M., JIA, W. X., and ZHANG, Y. H. Acta Polymerica Sinica, 1999, 2, 1000–3304.
  • Preparation of unilam ellar fusogenic liposom es using the Sendai virus. NAKANISHI, M., and MIZILGUCHL H. Nippon Y akurigaku Zasshi. Folia Pharmacologica Japonica, 1998, 112 (5), 299–305. 7 Refs.
  • Preparation of unsym m etrical m icrospheres at the interfaces. Fullmoro, K., NAKAHAMA, K., SHIDARA, M., and KAWAGUCHI, H. L angmuir, 1999, 15, 4630–4635.
  • Protective immunity of m icrosphere-based m ucosal vaccines against lethal intranasal challenge with Streptococcus pneum oniae. SEONG, S. Y., CHO, N. H., KWON, I. C., and JEONG, S. Y. Infection and Immunity, 1999, 67, 3587–3592.
  • Protein encapsulation in biodegradable am phiphilic m icrospheres. BOUILLOT, P., UBRICH, N., S OMMER, F., Duc, T. M., L OEFFLER, J. P., and D ELLACHERIE, E. International Journal of Pharmaceutics, 1999, 181, 159–172.
  • Protein instability tow ard organic solvent/w ater emulsification: implications for protein microencapsulation into microspheres. S AH, H. Pda Journal of Pharmaceutical Science and Technology, 1999, 53 (1), 3–10.
  • Pulm on ary distribution and clearance of two beclom ethasone liposom e form ulations in healthy volunteers. S AARI, M VA/CAEN, M T., KOSKINEN, M O., T URJANMAA, V. M., and NIEMENEN, M. M. International Journal of Pharmaceutics, 1999, 181 (1), 1–9.
  • Radioth erape u tic glass m icrospheres. Chemical Engineering Progress, 1999, 95, 14-15, News Item 5. Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and alpha-tocopherol in liposom es. FUKUZAWA, K., INoKAm[, Y., TOKUMURA,A., T ERAO, J., and S UZUKI, A. Lipids, 1998, 33 (8), 751–756.
  • Rhizobacteria microencapsulation: properties of m icroparticles obtained by spray-drying. A MIET CHARPENTIER, C., GADILLE, P., and B ENOIT, J. P. Journal of Microencapsulation, 1999, 16 (2), 215–229.
  • Ring-opening copolym erization of DL-lactide and poly(ethylene glycol) initiated by lantha-num acetate and application of the copolymer as matrix of microspheres containing Vibrio cholera antigens. DENG, X. M., LI, X. H., YUAN, M. L., LI, X. W., X TONG, C. D., HUANG, Z. T., and JIA, W. X. Chinese Journal of Polymer Science, 1999, 17, 265–270.
  • Selective delivery of doxorubicin to patients with breast carcinom a m etastases by stealth liposom es. S YMON, Z., PEYSER, A., T ZEMACH, D., L YASS, O., SucHER, E., SHEzw, E., and GABIZON, A. Cancer, 1999, 86 (1), 72–78.
  • Silicone microspheres for pH-controlled gastrointestinal drug delivery. CARELLI, V., COLTELLI, S., DI COLO, G., N ANNIPIERI, E., and S ERAFINI, M. F. International Journal of Pharmaceutics, 1999, 179 (1), 73–83.
  • Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. S CHWARZ, C., and M EHNERT, W. Journal of Microencap-sulation, 1999, 16 (2), 205–213.
  • Solubilization of liposom es by weak electrolyte drugs. II. Cefotaxime. R OCiERS, J. A., and H ABM, M. J. Journal of Microencapsulation, 1999, 16 (2), 141–151.
  • Solvent influence on spray-dried biodegradable microspheres. BAIN, D. F., M UNDAY, D. L., and SMITH, A. Journal of Microencapsulation, 1999, 16, 453–474.
  • Species differences in the proportion of plasm a lipoprotein lipid carried by high-density lipoproteins influence the distribution of free, and liposom al nystatin in hum an, dog,, and rat plasm a. RAMASWAMY, M., WALLACE, ALLACE, T. L., COSSUM, P. A.,, and W ASAN, K. M. Antimicrobial Agents and Chemotherapy, 1999, 43 (6), 1424–1428.
  • Specific binding and uptake of peptide ligand modified liposom es by PC12 cells. L OKHOV, P. G., IpAToyA, O. M., A BAKUMOVA, O., T SVETKOVA, T. A., and PROZOROVSKII, V. N. V oprosy Medit-sinskoi Khimii, 1999, 45 (2), 136–139.
  • Specific inhibitory effects of hybrid liposom es on the growth of various tumor cells. M ATSUMOTO, Y., K ATO, T., I SEKI, S S UZUKI, H., NAKANO, K., and UEOKA, R. Yakugaku Zasshi. Journal Of The Pharmaceutical Society Of Japan, 1999, 119 (4), 280–287.
  • Spray-dried m icroencapsulated Bacillus thuringiensis formulations for the control of Epilachna varivestis Mulsant. TAmEzGUERRA, P., GA8cIAGUTTERREZ, C., MED8ANoROLDAN, H., GALANWoNG, L. J., and SANDovALCoRoNADo, C. F. Southwestern Entomologist, 1999, 24, 37–48.
  • Stabilizing effect of an S-layer on liposom es tow ards therm al or mechanical stress. M ADER, C., KUPCU, S., SARA, ARA, M., and S LEYTR, U. B. Biochimica et Biophysica Acta, 1999, 1418 (1), 106–116.
  • Stealth m onensin liposom es as a potentiator of adriam ycin in cancer treatment. S INGH, M ., FERDOUS, A. J., and JACKSON, T. L. Journal of Controlled Release, 1999, 59 (1), 43–53.
  • Study on preparation and morphology of uniform artificial polystyrene-poly(m ethyl m eth a-crylate) composite microspheres by em ploying the SPG (Shirasu Porous Glass) m em - bran e emulsification technique. MA, G. H., NAGAI, M., and OM, S. Journal of Colloid and Interface Science, 1999, 214, 264–282.
  • Studies on the sorption of Pu(IV) on alumina m icrospheres from nitric acid-oxalic acid solutions. PIUS, I. C BHANUSHALI, R. D., PILLAI, K. T., M UKERJEE, S K., and V AIDYA, V. N. Journal of Radioanalytical and Nuclear Chemistry, 1999, 240, 981–985.
  • Successful treatm ent of candidal osteom yelitis with fiuconazole following failure with liposom al am photericin B. TURNER, D. L., JOHNSON, S A., and RULE, S. A. Journal of Infection, 1999, 38 (1), 51–53.
  • Successful use of liposom al am photericin Bin a case of am photericin B-induced nephrogenic diabetes insipidus. S PATH S CHWALBE, E., KOSCHUTH, A., DimZAIANN, A., S CHANZ, J., andPC6SINGER, K. Clinical Infectious Diseases, 1999, 28 (3), 680–681.
  • Surgically induced lum enolym phatic transference of m icrospheres: Interaction between bacterial LPS and extravasated m uscularis leukocytes. SCHWARZ, N. T., STOLZ, D. B., and BAUER, A. J. Gastroenterology, 1999, 116, S0247.
  • Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJliposom es. SAEKI, Y WATAYA KANEDA, M., TANAKA, K., and KANEDA, Y. Gene Therapy, 1998, 5 (8), 1031–1037.
  • Synthesis of cholesterol modified cationic lipids for liposom al drug delivery of antisense oligon u cle otid es. ZIMMER, A., AZIZ, S. A., GILBERT, M., WERNER, D., and NOE, C. R. European Journal of Pharmaceutics and Biopharmaceutics, 1999, 47 (2), 175–178.
  • Technology of getting of m icrospheric thorium dioxide. BALAKHONOV, V. G., MATYUKHA, V. A., SALTAN, N. P., FILIPPOV, E. A., and ZHIGANOV, A. N. Czechoslovak Journal of Physics, 1999, 49, 897–901.
  • Tem perature sensitization of liposom es using copolym ers of N-isopropylacrylam ide. HAYASHI, H., K ONO, K., and TAKAGISHI, T. Bioconjugate Chemistry, 1999, 10 (3), 412–418.
  • Tetracycline-HC1-loaded poly(DL-lactide-co-glycolide) m icrospheres prepared by a spray drying technique: influence of gamma-irradiation on radical form ation and polymer degradation. BITTNER, B., MADER, K., KROLL, C., BORCHERT, H. H., and KISSEL, T. Journal of Controlled Release, 1999, 59 (1), 23–32.
  • The acidic m icroclim ate in poly(lactide-co-glycolide) m icrospheres stabilizes cam pto-th e c in s. S HENDEROVA, A., BURKE, T G., and S CHWENDEMAN, S P. Pharmaceutical Research, 1999, 16 (2), 241–248.
  • The in vivo effect of liposom es on hem atopoiesis. Jovac, G., BUGARSKI, D., KATARANOVSKI, M., S TOJANOVIC, N., P ETAKOV, M M OJOVIC, L., and BUGARSKI, B. Drug Development and Industrial Pharmacy, 1999, 25 (4), 517–521.
  • The use of aqueous PEG dextran phase separation for the preparation of dextran m icro-sph eres. STENEKES, R. J. H., FRANSSEN, O., VAN BOMMEL, E. M. G., CROMMELIN, D. J. A., and HENNICK, W. E. International Journal of Pharmaceutics, 1999, 183, 29–32.
  • U.S. Food and Drug Administration approval of Am Bisom e (liposom al am photericin B) for treatment of visceral le ishm an iasis. MEYERHOFF, A. Clinical Infectious Diseases, 1999, 28 (1), 42–48; discussion 49–51. 24 Refs.
  • Visceral leishm an iasis associated with Wedisease. Use of lipid complex am ph ote ricinB and liposom al am photericin B. ZANALDI, H., ROSENTHAL, E., MARTY, P., CHICHMANIAN, R. M., PESCE, A., and CASSUTO, J. P. Presse Medicale, 1999, 28 (18), 959–961.
  • Why do m icroencapsulated islet grafts fail in the absence of fibrotic overgrow th? DE VC6, P., VAN STRAATEN, J. F. M., NIEUWENHUIZEN, A. G., DE GROOT, M., PLOEG, R. J., DE HAAN, P. J., and VAN SCHILFGAARDE, R. Diabetes, 1999, 48, 1381–1388.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.